BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

704 related articles for article (PubMed ID: 31420021)

  • 21. The effects of MDR/RR-TB treatment on HIV disease: A systematic review of literature.
    Geiger K; Stamper PD; Farley JE
    PLoS One; 2021; 16(3):e0248174. PubMed ID: 33667271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adverse events among HIV/MDR-TB co-infected patients receiving antiretroviral and second line anti-TB treatment in Mumbai, India.
    Isaakidis P; Varghese B; Mansoor H; Cox HS; Ladomirska J; Saranchuk P; Da Silva E; Khan S; Paryani R; Udwadia Z; Migliori GB; Sotgiu G; Reid T
    PLoS One; 2012; 7(7):e40781. PubMed ID: 22792406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multidrug-resistant and extensively drug-resistant tuberculosis: implications for the HIV epidemic and antiretroviral therapy rollout in South Africa.
    Andrews JR; Shah NS; Gandhi N; Moll T; Friedland G;
    J Infect Dis; 2007 Dec; 196 Suppl 3():S482-90. PubMed ID: 18181698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort study.
    Bastard M; Sanchez-Padilla E; du Cros P; Khamraev AK; Parpieva N; Tillyashaykov M; Hayrapetyan A; Kimenye K; Khurkhumal S; Dlamini T; Perez SF; Telnov A; Hewison C; Varaine F; Bonnet M
    PLoS One; 2018; 13(3):e0193491. PubMed ID: 29518098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High treatment failure and default rates for patients with multidrug-resistant tuberculosis in KwaZulu-Natal, South Africa, 2000-2003.
    Brust JC; Gandhi NR; Carrara H; Osburn G; Padayatchi N
    Int J Tuberc Lung Dis; 2010 Apr; 14(4):413-9. PubMed ID: 20202298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes of comprehensive care for children empirically treated for multidrug-resistant tuberculosis in a setting of high HIV prevalence.
    Satti H; McLaughlin MM; Omotayo DB; Keshavjee S; Becerra MC; Mukherjee JS; Seung KJ
    PLoS One; 2012; 7(5):e37114. PubMed ID: 22629356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved survival in multidrug-resistant tuberculosis patients receiving integrated tuberculosis and antiretroviral treatment in the SAPiT Trial.
    Padayatchi N; Abdool Karim SS; Naidoo K; Grobler A; Friedland G
    Int J Tuberc Lung Dis; 2014 Feb; 18(2):147-54. PubMed ID: 24429305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tuberculosis treatment outcomes in Ethiopia from 2003 to 2016, and impact of HIV co-infection and prior drug exposure: A systematic review and meta-analysis.
    Eshetie S; Gizachew M; Alebel A; van Soolingen D
    PLoS One; 2018; 13(3):e0194675. PubMed ID: 29554144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased risk of aminoglycoside-induced hearing loss in MDR-TB patients with HIV coinfection.
    Hong H; Budhathoki C; Farley JE
    Int J Tuberc Lung Dis; 2018 Jun; 22(6):667-674. PubMed ID: 29862952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intensive-phase treatment outcomes among hospitalized multidrug-resistant tuberculosis patients: results from a nationwide cohort in Nigeria.
    Oladimeji O; Isaakidis P; Obasanya OJ; Eltayeb O; Khogali M; Van den Bergh R; Kumar AM; Hinderaker SG; Abdurrahman ST; Lawson L; Cuevas LE
    PLoS One; 2014; 9(4):e94393. PubMed ID: 24722139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Addressing the drug-resistant tuberculosis challenge through implementing a mixed model of care in Uganda.
    Kasozi S; Kirirabwa NS; Kimuli D; Luwaga H; Kizito E; Turyahabwe S; Lukoye D; Byaruhanga R; Chen L; Suarez P
    PLoS One; 2020; 15(12):e0244451. PubMed ID: 33373997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment outcomes and predictive factors for multidrug-resistant TB and HIV coinfection in Rio de Janeiro State, Brazil.
    Bhering M; Duarte R; Kritski A
    Int J Tuberc Lung Dis; 2021 Apr; 25(4):292-298. PubMed ID: 33762073
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment and pregnancy outcomes of pregnant women exposed to second-line anti-tuberculosis drugs in South Africa.
    Mokhele I; Jinga N; Berhanu R; Dlamini T; Long L; Evans D
    BMC Pregnancy Childbirth; 2021 Jun; 21(1):453. PubMed ID: 34182944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tuberculosis associated mortality in a prospective cohort in Sub Saharan Africa: Association with HIV and antiretroviral therapy.
    Nagu TJ; Aboud S; Mwiru R; Matee MI; Rao M; Fawzi WW; Zumla A; Maeurer MJ; Mugusi F
    Int J Infect Dis; 2017 Mar; 56():39-44. PubMed ID: 28161460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Culture conversion among HIV co-infected multidrug-resistant tuberculosis patients in Tugela Ferry, South Africa.
    Brust JC; Lygizos M; Chaiyachati K; Scott M; van der Merwe TL; Moll AP; Li X; Loveday M; Bamber SA; Lalloo UG; Friedland GH; Shah NS; Gandhi NR
    PLoS One; 2011 Jan; 6(1):e15841. PubMed ID: 21253585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of TB/HIV co-infection: the state of the evidence.
    Torpey K; Agyei-Nkansah A; Ogyiri L; Forson A; Lartey M; Ampofo W; Akamah J; Puplampu P
    Ghana Med J; 2020 Sep; 54(3):186-196. PubMed ID: 33883764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Impact of Concurrent Antiretroviral Therapy and MDR-TB Treatment on Adverse Events.
    Smith JP; Gandhi NR; Shah NS; Mlisana K; Moodley P; Johnson BA; Allana S; Campbell A; Nelson KN; Master I; Brust JCM
    J Acquir Immune Defic Syndr; 2020 Jan; 83(1):47-55. PubMed ID: 31809360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment Adherence Among Persons Receiving Concurrent Multidrug-Resistant Tuberculosis and HIV Treatment in KwaZulu-Natal, South Africa.
    Stephens F; Gandhi NR; Brust JCM; Mlisana K; Moodley P; Allana S; Campbell A; Shah S
    J Acquir Immune Defic Syndr; 2019 Oct; 82(2):124-130. PubMed ID: 31513073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multidrug-resistant tuberculosis (MDR-TB) and multidrug-resistant HIV (MDR-HIV) syndemic: challenges in resource limited setting.
    Francisco C; Lansang MA; Salvana EM; Leyritana K
    BMJ Case Rep; 2019 Aug; 12(8):. PubMed ID: 31471363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for poor multidrug-resistant tuberculosis treatment outcomes in Kyiv Oblast, Ukraine.
    Aibana O; Bachmaha M; Krasiuk V; Rybak N; Flanigan TP; Petrenko V; Murray MB
    BMC Infect Dis; 2017 Feb; 17(1):129. PubMed ID: 28173763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.